David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COBZ
2551
DELISTED
CoBiz Financial,Inc
COBZ
| $1.18M | ﹤0.01% |
55,069
+13,205
| +32% | +$279K |
|
2552
PUT
NOV
NOV
$7.11B
| $1.18M | ﹤0.01% |
+27,200
| New | +$1.1M |
|
2553
Enpro
NPO
$6.42B
| $1.18M | ﹤0.01% |
16,866
+7,737
| +85% | +$578K |
|
2554
PUT
Teleflex
TFX
$5.94B
| $1.18M | ﹤0.01% |
4,400
-10,000
| -69% | -$2.68M |
|
2555
Stryker
SYK
$127B
| $1.18M | ﹤0.01% |
+6,975
| New | +$1.17M |
|
2556
PUT
BlackBerry
BB
$4.57B
| $1.18M | ﹤0.01% |
122,000
+20,000
| +20% | +$223K |
|
2557
PUT
T-Mobile US
TMUS
$195B
| $1.18M | ﹤0.01% |
19,700
| – | – |
|
2558
Materion
MTRN
$4.84B
| $1.18M | ﹤0.01% |
21,714
-29,700
| -58% | -$1.61M |
|
2559
Ocular Therapeutix
OCUL
$2.39B
| $1.18M | ﹤0.01% |
+174,023
| New | +$1.2M |
|
2560
Rhythm Pharmaceuticals
RYTM
$7.8B
| $1.18M | ﹤0.01% |
+37,575
| New | +$1.03M |
|
2561
Grupo Cibest SA
CIB
$24.4B
| $1.17M | ﹤0.01% |
24,524
-22,898
| -48% | -$1.08M |
|
2562
PUT
Trinity Industries
TRN
$2.36B
| $1.17M | ﹤0.01% |
47,504
| – | – |
|
|
B
2563
CALL
Barrick Mining
B
$80.4B
| $1.17M | ﹤0.01% |
89,200
+52,800
| +145% | +$692K |
|
|
HBI
2564
PUT
DELISTED
Hanesbrands
HBI
| $1.17M | ﹤0.01% |
53,100
+31,800
| +149% | +$600K |
|
2565
Ingredion
INGR
$6.62B
| $1.17M | ﹤0.01% |
10,554
+7,554
| +252% | +$888K |
|
2566
Park Hotels & Resorts
PK
$3.26B
| $1.17M | ﹤0.01% |
38,100
-384,844
| -91% | -$11.5M |
|
2567
Ryman Hospitality Properties
RHP
$9.17B
| $1.16M | ﹤0.01% |
14,002
+1,500
| +12% | +$121K |
|
2568
Ennis
EBF
$543M
| $1.16M | ﹤0.01% |
57,128
+30,654
| +116% | +$582K |
|
|
HCOM
2569
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $1.16M | ﹤0.01% |
40,227
+4,526
| +13% | +$125K |
|
2570
Rafael Holdings
RFL
$116M
| $1.16M | ﹤0.01% |
128,297
+45,401
| +55% | +$358K |
|
|
UNIT
2571
PUT
Uniti Group
UNIT
$2.45B
| $1.16M | ﹤0.01% |
58,000
| – | – |
|
2572
PUT
Enanta Pharmaceuticals
ENTA
$410M
| $1.16M | ﹤0.01% |
10,000
| – | – |
|
2573
WSFS Financial
WSFS
$4.01B
| $1.15M | ﹤0.01% |
21,588
+9,567
| +80% | +$496K |
|
2574
Standard BioTools
LAB
$255M
| $1.15M | ﹤0.01% |
193,007
+55,376
| +40% | +$316K |
|
2575
CALL
Southwest Airlines
LUV
$20B
| $1.15M | ﹤0.01% |
+22,600
| New | +$1.19M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.